Article

newatlas.comnewatlas.com on 2023-03-22 02:49

Promising ovarian cancer drug in phase 3 clinical trials

Ovarian cancer is marked by low survival rates and a high rate of recurrence despite treatment. But a promising cancer-fighting drug is undergoing ...

Related news